Profound retinal ischaemia after ranibizumab administration in an eye with ocular ischaemic syndrome
October 15th, 2009 Posted by: admin
Purpose: To report the result of ranibizumab administration in an eye with ocular ischaemic syndrome.Methods: Fluorescein angiography, ocular pneumoplethysmography and retinal vessel calibre measurement.Results: An 85-year-old man with ocular ischaemic syndrome demonstrated vision loss, retinal vessel calibre constriction and profound retinal ischaemia after intravitreal ranibizumab.Conclusion: We advise against the use of intravitreal vascular endothelial growth factor inhibitors in eyes with ocular ischaemic syndrome.
